Eiko Lifesciences Ltd Financials

Eiko Lifesciences Ltd Financial Statement

Eiko Lifesciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars	Sep 2024	Jun 2024	Mar 2024
Revenue	7.87	11.01	8.50
Operating Expense	7.39	10.36	7.88
Net Profit	0.21	0.35	0.31
Net Profit Margin	2.67	3.18	3.65
Earning Per Share	0.16	0.27	0.28
EBIDTA	0.46	0.64	0.61
Effective Tax Rate	10.42	13.64	15.87

Particulars	Sep 2024
Revenue	7.87
Operating Expense	7.39
Net Profit	0.21
Net Profit Margin	2.67
Earning Per Share	0.16
EBIDTA	0.46
Effective Tax Rate	10.42

Eiko Lifesciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Total Revenue Annual	27.93	18.32	25.41
Operating Expenses Annual	26.32	17.37	24.12
Operating Profit Annual	1.79	1.81	1.97
Interest Annual	0.14	0.15	0.46
Depreciation	0.66	0.63	0.56
Net Profit Annual	0.75	0.77	0.71
Tax Annual	0.23	0.26	0.24

Particulars	Mar 2024
Total Revenue Annual	27.93
Operating Expenses Annual	26.32
Operating Profit Annual	1.79
Interest Annual	0.14
Depreciation	0.66
Net Profit Annual	0.75
Tax Annual	0.23

Eiko Lifesciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Cash Flow at the Beginning	0.61	0.22	4.07
Cash Flow from Operations	-7.08	4.22	-7.73
Cash Flow from Investing	-0.55	0.87	0.59
Cash Flow from Financing	20.36	-4.70	3.28
Cash Flow at the End	13.35	0.61	0.22

Particulars	Mar 2024
Cash Flow at the Beginning	0.61
Cash Flow from Operations	-7.08
Cash Flow from Investing	-0.55
Cash Flow from Financing	20.36
Cash Flow at the End	13.35

Eiko Lifesciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
PBDIT Margin (%)	6.44	9.93	7.79
PBIT Margin (%)	4.08	6.50	5.59
PBT Margin (%)	-22.88	-34.11	-6.14
Net PROFIT Margin (%)	2.69	4.20	2.79
Return On Networth / Equity (%)	1.87	2.65	3.45
Return On Networth /Employed (%)	2.82	3.79	6.01
Return On Assets (%)	1.88	2.44	2.99
Total Debt / Equity (X)	TBA	0.08	0.16
Asset Turnover Ratio (%)	0.70	0.58	1.07

Particulars	Mar 2024
PBDIT Margin (%)	6.44
PBIT Margin (%)	4.08
PBT Margin (%)	-22.88
Net PROFIT Margin (%)	2.69
Return On Networth / Equity (%)	1.87
Return On Networth /Employed (%)	2.82
Return On Assets (%)	1.88
Total Debt / Equity (X)	TBA
Asset Turnover Ratio (%)	0.70

Eiko Lifesciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2024	Mar 2023	Mar 2022
Fixed Assets Annual	13.57	13.88	14.29
Total Current Assets Annual	30.93	9.30	12.44
Non Current Assets Annual	21.81	21.74	22.46
Total Shareholders Funds Annual	50.68	29.42	28.63
Total Assets Annual	52.74	31.04	34.89

Particulars	Mar 2024
Fixed Assets Annual	13.57
Total Current Assets Annual	30.93
Non Current Assets Annual	21.81
Total Shareholders Funds Annual	50.68
Total Assets Annual	52.74

Eiko Lifesciences Ltd Earning Calls

EPS (INR)

Expected

0.22

Reported

0.22

Surprise

0.00%

Jun 2024

EPS beaten by 0.00%

Sep 2020

EPS beaten by 0.00%

Jun 2020

EPS beaten by 0.00%

Dividend Pages

PE Ratio

Get Your FAQs Right

As of Dec 26, 2024, Eiko Lifesciences Ltd has a market capitalization of 60.18 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Eiko Lifesciences Ltd is debt-free with a debt-to-equity ratio of 0.00.

In FY 2023 , Eiko Lifesciences Ltd recorded a total revenue of approximately 27.93 Cr marking a significant milestone in the company's financial performance.

Eiko Lifesciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.2% and 0.0% annually, respectively..

Eiko Lifesciences Ltd's current PE ratio is 80.24.

Eiko Lifesciences Ltd's ROCE averaged 3.5% from the FY ending March 2022 to 2024, with a median of 4.0%. It peaked at 4.2% in March 2022, reflecting strong capital efficiency over the period..

Eiko Lifesciences Ltd's latest EBIT is Rs. 1.12 Cr, surpassing the average EBIT of Rs. 1.23 Cr over the 5 years..